lirentelimab (AK002) - Allakos
|
ligelizumab (QGE 031) - Novartis
|
Cinqair (reslizumab) - Merck (MSD), UCB, Teva
|
Xolair (omalizumab) - Roche, Novartis
|
LY3454738 - Eli Lilly
|
tezepelumab (AMG 157) - AstraZeneca, Amgen
|
Cosentyx (secukinumab) - Novartis
|
Nucala (mepolizumab) - GSK
|
CDX-0159 - Celldex
|
Fasenra (benralizumab) - AstraZeneca
|
Dupixent (dupilumab) - Sanofi, Regeneron
|
avdoralimab (IPH5401) - Innate
|